Blood Cancer Information

In this section you will find disease specific information on the main types of blood cancers and allied blood disorders.

Leukaemia

Leukaemia is a cancer which starts in blood-forming tissue, usually the bone marrow. It leads to the over-production of abnormal white blood cells, the part of the immune system which defends the body against infection.

Signs and symptoms of leukaemia

Leukaemia can be hard to spot because the signs and symptoms are common to other unrelated illnesses. Knowing what to look out for could help you make the decision to visit your GP sooner for a blood test.

Leukaemia Myths

There are many myths about leukaemia. Get yourself clued up with the following guide

Lymphoma

Lymphoma is cancer that starts in the lymph glands or other organs of the lymphatic system. The lymphatic system is a network of fine vessels, glands and channels which occur throughout the body.

Myeloma

Myeloma, also known as multiple myeloma, is a cancer of the bone marrow which affects the plasma cells, a type of blood cell.

Aplastic Anaemia

Aplastic anaemia (AA) is a rare condition in which the bone marrow fails produce all three major types of blood cell. It is not a form of cancer.

Myeloproliferative neoplasms (MPN)

Myeloproliferative neoplasms, also known as myeloproliferative disorders (MPDs) are a group of conditions that are closely related to leukaemia.

Myelodysplastic syndromes (MDS)

Myelodysplastic syndromes (MDS) are diseases of the bone marrow. MDS is characterised by abnormal, immature blood cells that do not work properly. MDS is a type of cancer, but it is sometimes also called ‘bone marrow failure’. Here, we cover what MDS is, how it’s diagnosed, and what treatment you might have.

Share your fundraising story

Tell the world that your fundraising for Leukaemia Care and more importantly why you chose to support our charity. Sharing your fundraising story can sometimes give your sponsorship that extra boost to help you raise even more money!

Read More

Take a Moment to Catch Up

View our latest news and blog articles

April 23rd

Cost of leukaemia – Tony Pullen on sick pay

Tony Pullen talks openly about how being diagnosed with hairy cell leukaemia (HCL) has impacted his financial stability. ...

April 11th

Approval for the first CAR-T treatment for ALL is renewed

CAR-T therapy, tisagenlecleucel, has been given long term approval to be used on the NHS in England, thanks to a decision made by the National Institute for Health and Care Excellence's (NICE). ...

March 11th

NEW oral treatment for AML patients approved in Scotland

Leukaemia Care are pleased to announce that newly diagnosed acute myeloid leukaemia (AML) patient with an IDH1 mutation who are ineligible for standard induction chemotherapy now have access to ivosidenib with azacitidine thanks to the decision made by the Scottish Medicines Consortium (SMC) today....